Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, P. M.
Right arrow Articles by Persaud, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, P. M.
Right arrow Articles by Persaud, S. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:S172-S178, 2004
© 2004 by the American Diabetes Association, Inc.


Section IV: Lipid Modulators of Islet Function

The Role of Cytosolic Phospholipase A2 in Insulin Secretion

Peter M. Jones, Christopher J. Burns, Véronique D. Belin, Helen M. Roderigo-Milne, and Shanta J. Persaud

From the Centre for Reproduction, Endocrinology and Diabetes, GKT School of Biomedical Sciences, King’s College London, London, U.K

Cytosolic phospholipase A2 (cPLA2) comprises a widely expressed family of enzymes, some members of which have the properties required of signal transduction elements in electrically excitable cells. Thus, {alpha}- and ß-isoforms of cPLA2 are activated by the increases in intracellular Ca2+ concentration ([Ca2+]i) achieved in depolarized cells. Activation is associated with a redistribution of the enzyme within the cell; activation of cPLA2 generates arachidonic acid (AA), a biologically active unsaturated fatty acid that can be further metabolized to generate a plethora of biologically active molecules. Studies using relatively nonselective pharmacological inhibitors have implicated cPLA2 in insulin secretory responses to stimuli that elevate ß-cell [Ca2+]i; therefore, we have investigated the role of cPLA2 in ß-cell function by generating ß-cell lines that under- or overexpress the {alpha}-isoform of cPLA2. The functional phenotype of the modified cells was assessed by observation of cellular ultrastructure, by measuring insulin gene expression and insulin protein content, and by measuring the effects of insulin secretagogues on cPLA2 distribution, on changes in [Ca2+]i, and on the rate and pattern of insulin secretion. Our results suggest that cPLA2 is not required for the initiation of insulin secretion from ß-cells, but that it plays an important role in the maintenance of ß-cell insulin stores. Our data also demonstrate that excessive production of, or exposure to, AA is deleterious to normal ß-cell secretory function through metabolic dysfunction.


Address correspondence and reprint requests to P.M. Jones, Room 3.2A, New Hunt’s House, CRED, GKT School of Biomedical Sciences, King’s College London, London SE1 1UL, U.K. E-mail: peter.jones{at}kcl.ac.uk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. J. Persaud, D. Muller, V. D. Belin, I. Kitsou-Mylona, H. Asare-Anane, A. Papadimitriou, C. J. Burns, G. C. Huang, S. A. Amiel, and P. M. Jones
The Role of Arachidonic Acid and Its Metabolites in Insulin Secretion From Human Islets of Langerhans
Diabetes, January 1, 2007; 56(1): 197 - 203.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.